The incidence of relative adrenal insufficiency in patients with septic shock after the administration of etomidate
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Introduction: Etomidate blocks adrenocortical synthesis when it is administered intravenously as a continuous infusion or a single bolus. The influence of etomidate administration on the incidence of relative adrenal insufficiency in patients with septic shock has not been formally investigated. The objective of this study was to determine the incidence of relative adrenal insufficiency in patients with septic shock after etomidate administration compared with patients with septic shock who did not receive etomidate. Methods: In this retrospective study, 152 adults with septic shock who had a consyntropin stimulation test between March 2002 and August 2003 in a tertiary medical center were included. Relative adrenal insufficiency was defined as a rise in serum cortisol ≤ 9 μg/dl after the administration of 250 μg of consyntropin. Patients were divided into those who did and those who did not receive etomidate before the stimulation test. The proportion of patients with relative adrenal insufficiency in these two groups was compared using Fischer's exact test. A P of value < 0.05 was considered statistically significant. Results: The mean age of the patients was 64 years, 59% of patients were male, 97% of patients were white and their hospital mortality rate was 57%. Thirty-eight patients (25%) received etomidate before the cosyntropin stimulation test, and the median (interquartile range) time interval between the administration of the drug and the test was 7 (4–10) hours. The incidence of relative adrenal insufficiency was 76% in the patients who received etomidate compared with 51% in the patients who did not (P = 0.0077). Conclusion: The incidence of relative adrenal insufficiency in patients with septic shock is increased when the stimulation test is performed after the administration of etomidate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Annane, D. (2000) · JAMA · doi:10.1001/jama.283.8.1038 · Cited by 1,000 · cited 3×
“Relative adrenal insufficiency was defined as a rise in serum cortisol ≤ 9 μg/dl [1].”
BackgroundResultAdrenocortical function in critically ill patients 24 h after a single dose of etomidate
Absalom, Pledger, & Kong (1999) · Anaesthesia · doi:10.1046/j.1365-2044.1999.01003.x · Cited by 241
Malerba, G., Romano-Girard, F., Cravoisy, A., Dousset, B., Nace, L., L�vy, B., & Bollaert, P.-E. (2005) · Intensive Care Medicine · doi:10.1007/s00134-004-2550-8 · Cited by 179 · cited 2×
“In critically ill patients, a single dose of etomidate suppresses adrenal function for approximately 24 hours [4,6].”
Background
Cited by
Jabre, P., Combes, X., Lapostolle, F., Dhaouadi, M., Ricard-Hibon, A., Vivien, B., Bertrand, L., Beltramini, A., Gamand, P., Albizzati, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60949-1 · Cited by 562
Clinical and Molecular Pharmacology of Etomidate
Forman, S. A., & Warner, D. S. (2011) · Anesthesiology · doi:10.1097/aln.0b013e3181ff72b5 · Cited by 361
Simpson, G. D., Ross, M. J., McKeown, D. W., & Ray, D. C. (2012) · British Journal of Anaesthesia · doi:10.1093/bja/aer504 · Cited by 267
Hildreth, A. N., Mejia, V. A., Maxwell, R. A., Smith, P. W., Dart, B. W., & Barker, D. E. (2008) · Journal of Trauma: Injury, Infection & Critical Care · doi:10.1097/ta.0b013e31818255e8 · Cited by 197
Drug-induced endocrine disorders in the intensive care unit
Thomas, Z., Bandali, F., McCowen, K., & Malhotra, A. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181dda0f2 · Cited by 30
Metadata
- Authors
- Mohammad, Z., Afessa, B., & Finkielman, J. D.
- Venue
- Critical Care
- Published
- 2006-07-19
- Volume
- 10
- Issue
- 4
- Pages
- R105-R105
- ISSN
- 1364-8535 (ISSN-L)
- OpenAlex
- W2169011232
- Cited by
- 87
- References
- 3
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.